Coexpression of angiogenic factors in brain arteriovenous malformations

Neurosurgery

Volumn 56, Issue 5, 2005, Pages 1058-1065

  Hashimoto, Tomoki ^a,b   Wu, Yongqin ^a   Lawton, Michael T ^b   Yang, Guo Yuan ^a   Barbaro, Nicholas M ^b   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Arteriovenous malformations; Endothelium; Growth factors cytokines

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; GELATINASE B; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN;

ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANGIOPOIETIN-2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MATRIX METALLOPROTEINASE 9; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 18244390729     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000157925.19676.C3     Document Type: Article

References (34)

1. Anonymous: Arteriovenous malformations of the brain in adults. N Engl J Med 340:1812-1818, 1999.
2. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401-410, 2003.
3. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Wetb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744, 2000.
4. Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M: Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156:911-923,2000.
5. Carmeliet P: Angiogenesis in health and disease. Nat Med 9:653-660, 2003.
6. Duong DH, Young WL, Vang MC, Sciacca RR, Mast H, Koennecke HC, Hartmann A, Joshi S, Mohr JP, Pile-Spellman J: Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 29:1167-1176, 1998.
7. Fleetwood IG, Steinberg GK: Arteriovenous malformations. Lancet 359:863-873, 2002.
8. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 277:48-50, 1997.
9. Harrigan MR: Angiogenic factors in the central nervous system. Neurosurgery 53:639-661, 2003.
10. Hashimoto T, Emala CW, Joshi S, Mesa-Tejada R, Quick CM, Feng L, Libow A, Marchuk DA, Young WL: Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47:910-919, 2000.
11. Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL: Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89:111-113, 2001.
12. Hashimoto T, Mesa-Tejada R, Quick CM, Bollen AW, Joshi S, Pile-Spellman J, Lawton MT, Young WL: Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 49:124-132, 2001.
13. Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbara NM, Higashida RT, Dowd CF, Halbach W, Young WL: Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34:925-931, 2003.
14. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 55:1124-1133, 1996.
15. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153:543-553, 2001.
16. Joint Writing Group of the Technology Assessment Committee ASoIaTN, Joint Section on Cerebrovascular Neurosurgery, a Section of American Association of Neurological Surgeons and Congress of Neurological Surgeons, and Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology: Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 32:1430-1442, 2001.
17. Kader A, Young WL, Pile-Spellman J, Mast H, Sciacca RR, Mohr JP, Stein BM: The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 34:801-808, 1994.
18. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PMcL: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1192, 2000.
19. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T: Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 50:117-126, 2002.
20. Marks MP, Lane B, Steinberg GK, Chang PJ: Hemorrhage in intracerebral arteriovenous malformations: Angiographic determinants. Radiology 176:807-813, 1990.
21. Matsubara S, Bourdeau A, ter Brugge KG, Wallace C, Letarte M: Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke 31:2653-2660, 2000.
22. Rhoten RL, Comair YG, Shedid D, Chyatte D, Simonson MS: Specific repression of the preproendothelin-1 gene in intracranial arteriovenous malformations. J Neurosurg 86:101-108, 1997.
23. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-925, 1996.
24. Shenkar R, Elliott JP, Diener K, Gault J, Hu LJ, Cohrs RJ, Phang T, Hunter L, Breeze RE, Awad IA: Differential gene expression in human Cerebrovascular malformations. Neurosurgery 52:465-478, 2003.
25. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D: Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: An immunocytochemical study. J Neurosurg 85:838-845, 1996.
26. Spetzler RF, Hargraves RW, McCormick PW, Zabramski JM, Flom RA, Zimmerman RS: Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 76:918-923, 1992.
27. Stapf C, Khaw AV, Sciacca RR, Hofmeister C, Schumacher HC, Pile-Spellman J, Mast H, Mohr JP, Hartmann A: Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke 34:2664-2669, 2003.
28. Stefani MA, Porter PJ, ter Brugge KG, Montanera W, Willinsky RA, Wallace MC: Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke 33:920-924, 2002.
29. Stefani MA, Porter PJ, ter Brugge KG, Montanera W, Willinsky RA, Wallace MC: Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 33:1220-1224, 2002.
30. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H: Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103:29-32, 2001.
31. Uranishi R, Awadallah NA, Ogunshola CO, Awad IA: Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery 50:110-116, 2002.
32. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA: Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48:359-368, 2001.
33. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR: Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase tie2. Cell 87:1181-1190, 1996.
34. Vu TH, Werb Z: Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 14:2123-2133, 2000.